Literature DB >> 21984061

Do GP referral guidelines really work? Audit of an electronic urgent referral system for suspected head and neck cancer.

Ann-Maree Kennedy1, Abdul Aziz, Sameena Khalid, David Hurman.   

Abstract

We adapted the 2002 Scottish Referral Guidelines for suspected squamous cell carcinoma of the head and neck (SCCHN) as a set of "alarm symptoms." These were then incorporated into a new Suspected Cancer Urgent Referral Electronically (SeCURE) system enabling immediate electronic referral from primary care to the appropriate hospital-based multi-disciplinary cancer team. All referrals made via the SeCURE system during the first year of its implementation were reviewed retrospectively. One hundred and ninety patients were urgently referred, of whom 15 (8%) were ultimately diagnosed with SCCHN. This audit demonstrated overall poor compliance with the referral guidelines. Although the electronic referral system helped for speedy clinic appointments, there was a low pick up rate of positive head and neck cancer cases. Continuing education for GPs is important and following discussion with colleagues in primary care, steps have been taken to reinforce awareness and more appropriate use of the SeCURE system.

Entities:  

Mesh:

Year:  2011        PMID: 21984061     DOI: 10.1007/s00405-011-1788-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  9 in total

1.  Impact of the '2 week wait' directive for suspected cancer on service provision in a symptomatic breast clinic.

Authors:  P J Cant; D S Yu
Journal:  Br J Surg       Date:  2000-08       Impact factor: 6.939

2.  Two-week rule for suspected head and neck cancer. A study of compliance and effectiveness.

Authors:  Shyam Kiran Duvvi; Ligy Thomas; Sreedharan Vijayanand; Krishna T V Reddy
Journal:  J Eval Clin Pract       Date:  2006-12       Impact factor: 2.431

3.  Fast-track referrals for oral lesions: a prospective study.

Authors:  H V Shah; R W Williams; G H Irvine
Journal:  Br J Oral Maxillofac Surg       Date:  2005-07-01       Impact factor: 1.651

4.  The two-week wait cancer initiative on oral cancer; the predictive value of urgent referrals to an oral medicine unit.

Authors:  P Singh; S Warnakulasuriya
Journal:  Br Dent J       Date:  2006-12-09       Impact factor: 1.626

5.  Has the breast cancer 'two week wait' guarantee for assessment made any difference?

Authors:  A R Khawaja; S M Allan
Journal:  Eur J Surg Oncol       Date:  2000-09       Impact factor: 4.424

6.  Audit of referrals for head and neck cancer - the effect of the 2-week, fast track referral system.

Authors:  M Lyons; J Philpott; I Hore; G Watters
Journal:  Clin Otolaryngol Allied Sci       Date:  2004-04

7.  The 2-week rule for suspected head and neck cancer in the United Kingdom: referral patterns, diagnostic efficacy of the guidelines and compliance.

Authors:  C McKie; U A Ahmad; S Fellows; D Meikle; F W Stafford; P J Thomson; A R Welch; V Paleri
Journal:  Oral Oncol       Date:  2008-01-29       Impact factor: 5.337

8.  Outcomes for patients referred urgently with suspected head and neck cancer.

Authors:  J C Hobson; J V Malla; J Sinha; N J Kay; L Ramamurthy
Journal:  J Laryngol Otol       Date:  2008-03-27       Impact factor: 1.469

9.  Auditing the diagnosis of cancer in primary care: the experience in Scotland.

Authors:  P Baughan; B O'Neill; E Fletcher
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

  9 in total
  2 in total

Review 1.  Referral interventions from primary to specialist care: a systematic review of international evidence.

Authors:  Lindsay Blank; Susan Baxter; Helen Buckley Woods; Elizabeth Goyder; Andrew Lee; Nick Payne; Melanie Rimmer
Journal:  Br J Gen Pract       Date:  2014-12       Impact factor: 5.386

Review 2.  Factors affecting the successful implementation of the referral system: A scoping review.

Authors:  Maryam Seyed-Nezhad; Batoul Ahmadi; Ali Akbari-Sari
Journal:  J Family Med Prim Care       Date:  2021-12-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.